Q&A with James List, MD, PhD, from Janssen Research and Development: Diabetic Kidney Disease and Treatments for a Growing Healthcare Problem
Diabetic kidney disease can take various forms and affect patients in different ways. How the disease progresses and what can be done to slow that progression is the focus of many researchers in the field.
Diabetic kidney disease can take various forms and affect patients in different ways. How the disease progresses and what can be done to slow that progression is the focus of many researchers in the field.
James List, MD, PhD, Global Therapeutic Area Head, Cardiovascular and Metabolism at Janssen Research and Development discussed why the condition has become a growing concern and what is being done to address the issue through new medications and therapies.
With two medications moving through the pipeline, patients with diabetic kidney disease may soon get a new treatment to prevent their developing end stage kidney disease.
When new medications are developed there are certain questions that usually come with their introduction to patients. These include the safety profile, how the treatments are delivered, and what they will cost for patients. The answers to those questions can sometimes make the difference in the treatment's utilization and success in reaching its goals.
